rs768950814

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PM4_SupportingBP6BS1BS2

The NM_001127222.2(CACNA1A):​c.6658_6659insACC​(p.His2219dup) variant causes a conservative inframe insertion change. The variant allele was found at a frequency of 0.00772 in 1,459,614 control chromosomes in the GnomAD database, including 51 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P2220P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0080 ( 12 hom., cov: 31)
Exomes 𝑓: 0.0077 ( 39 hom. )

Consequence

CACNA1A
NM_001127222.2 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 5.98

Publications

2 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_001127222.2. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 19-13208877-G-GGGT is Benign according to our data. Variant chr19-13208877-G-GGGT is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210557.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00801 (1206/150552) while in subpopulation AFR AF = 0.0144 (589/40972). AF 95% confidence interval is 0.0134. There are 12 homozygotes in GnomAd4. There are 563 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1206 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.6658_6659insACC p.His2219dup conservative_inframe_insertion Exon 46 of 47 ENST00000360228.11 NP_001120694.1 O00555-8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.6658_6659insACC p.His2219dup conservative_inframe_insertion Exon 46 of 47 1 NM_001127222.2 ENSP00000353362.5 O00555-8
CACNA1AENST00000638029.1 linkc.6676_6677insACC p.His2225dup conservative_inframe_insertion Exon 47 of 48 5 ENSP00000489829.1 A0A087WW63
CACNA1AENST00000573710.7 linkc.6664_6665insACC p.His2221dup conservative_inframe_insertion Exon 46 of 47 5 ENSP00000460092.3 A0A1C7CYY9
CACNA1AENST00000635727.1 linkc.6661_6662insACC p.His2220dup conservative_inframe_insertion Exon 46 of 47 5 ENSP00000490001.1 A0A1B0GU81
CACNA1AENST00000637769.1 linkc.6661_6662insACC p.His2220dup conservative_inframe_insertion Exon 46 of 47 1 ENSP00000489778.1 A0A1B0GTN7
CACNA1AENST00000636012.1 linkc.6625_6626insACC p.His2208dup conservative_inframe_insertion Exon 45 of 46 5 ENSP00000490223.1 A0A1B0GUS3
CACNA1AENST00000637736.1 linkc.6520_6521insACC p.His2173dup conservative_inframe_insertion Exon 45 of 46 5 ENSP00000489861.1 A0A1B0GTW2
CACNA1AENST00000636389.1 linkc.6661_6662insACC p.His2220dup conservative_inframe_insertion Exon 46 of 47 5 ENSP00000489992.1 A0A1B0GU74
CACNA1AENST00000637432.1 linkc.6676_6677insACC p.His2225dup conservative_inframe_insertion Exon 47 of 48 5 ENSP00000490617.1 O00555-2
CACNA1AENST00000636549.1 linkc.6667_6668insACC p.His2222dup conservative_inframe_insertion Exon 47 of 48 5 ENSP00000490578.1 B5TYJ1
CACNA1AENST00000637927.1 linkc.6664_6665insACC p.His2221dup conservative_inframe_insertion Exon 46 of 47 5 ENSP00000489715.1 A0A1B0GTI4
CACNA1AENST00000635895.1 linkc.6661_6662insACC p.His2220dup conservative_inframe_insertion Exon 46 of 47 5 ENSP00000490323.1 A0A384DVW2
CACNA1AENST00000638009.2 linkc.6661_6662insACC p.His2220dup conservative_inframe_insertion Exon 46 of 47 1 ENSP00000489913.1 O00555-3
CACNA1AENST00000637276.1 linkc.6625_6626insACC p.His2208dup conservative_inframe_insertion Exon 45 of 46 5 ENSP00000489777.1 O00555-5
CACNA1AENST00000636768.2 linkn.*924_*925insACC non_coding_transcript_exon_variant Exon 44 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*1837_*1838insACC non_coding_transcript_exon_variant Exon 46 of 47 ENSP00000519091.1
CACNA1AENST00000636768.2 linkn.*924_*925insACC 3_prime_UTR_variant Exon 44 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*1837_*1838insACC 3_prime_UTR_variant Exon 46 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
AF:
0.00797
AC:
1199
AN:
150444
Hom.:
12
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0143
Gnomad AMI
AF:
0.00664
Gnomad AMR
AF:
0.00482
Gnomad ASJ
AF:
0.00665
Gnomad EAS
AF:
0.00697
Gnomad SAS
AF:
0.00886
Gnomad FIN
AF:
0.000863
Gnomad MID
AF:
0.0223
Gnomad NFE
AF:
0.00585
Gnomad OTH
AF:
0.0111
GnomAD2 exomes
AF:
0.00868
AC:
1019
AN:
117448
AF XY:
0.00894
show subpopulations
Gnomad AFR exome
AF:
0.0172
Gnomad AMR exome
AF:
0.00726
Gnomad ASJ exome
AF:
0.0114
Gnomad EAS exome
AF:
0.00947
Gnomad FIN exome
AF:
0.00152
Gnomad NFE exome
AF:
0.00596
Gnomad OTH exome
AF:
0.00851
GnomAD4 exome
AF:
0.00768
AC:
10058
AN:
1309062
Hom.:
39
Cov.:
74
AF XY:
0.00774
AC XY:
5008
AN XY:
646624
show subpopulations
African (AFR)
AF:
0.0184
AC:
532
AN:
28984
American (AMR)
AF:
0.00696
AC:
236
AN:
33890
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
250
AN:
24010
East Asian (EAS)
AF:
0.00652
AC:
215
AN:
32960
South Asian (SAS)
AF:
0.0119
AC:
906
AN:
76330
European-Finnish (FIN)
AF:
0.00140
AC:
45
AN:
32216
Middle Eastern (MID)
AF:
0.00932
AC:
49
AN:
5256
European-Non Finnish (NFE)
AF:
0.00713
AC:
7281
AN:
1020678
Other (OTH)
AF:
0.00994
AC:
544
AN:
54738
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.405
Heterozygous variant carriers
0
478
957
1435
1914
2392
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00801
AC:
1206
AN:
150552
Hom.:
12
Cov.:
31
AF XY:
0.00766
AC XY:
563
AN XY:
73524
show subpopulations
African (AFR)
AF:
0.0144
AC:
589
AN:
40972
American (AMR)
AF:
0.00482
AC:
73
AN:
15152
Ashkenazi Jewish (ASJ)
AF:
0.00665
AC:
23
AN:
3460
East Asian (EAS)
AF:
0.00719
AC:
36
AN:
5006
South Asian (SAS)
AF:
0.00929
AC:
44
AN:
4734
European-Finnish (FIN)
AF:
0.000863
AC:
9
AN:
10434
Middle Eastern (MID)
AF:
0.0276
AC:
8
AN:
290
European-Non Finnish (NFE)
AF:
0.00585
AC:
395
AN:
67510
Other (OTH)
AF:
0.0110
AC:
23
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
52
104
155
207
259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00306
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:3
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 27, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Jan 29, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 13, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1A: PM4:Supporting, BS1, BS2 -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 07, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

CACNA1A-related disorder Benign:1
Jul 01, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.0
Mutation Taster
=74/26
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768950814; hg19: chr19-13319691; API